Structure and expression of adenovirus type 12 E1B 58K protein in infected and transformed cells: studies using antibodies directed against a synthetic peptide. 1985

K Schughart, and E Bause, and H Esche

We have studied the kinetics of synthesis of the early adenovirus type 12 (Ad12) E1B 58K tumor antigen during lytic infection and analysed its half-life, intracellular localization and phosphorylation in infected KB and transformed hamster (HA12/7) cells. Our analysis has been based on immunoprecipitations using antibodies directed against a synthetic peptide corresponding to the carboxy-terminal end of the E1B 58K protein. Its synthesis was first detectable approximately 8 h after infection and reached a maximum at about 20 h. There is a slight decrease of synthesis late after infection although its level of production is rather high throughout the infectious cycle. The half-life of the Ad12 E1B 58K polypeptide is 2-3 h in infected cells, but strikingly higher (less than 10 h) in the Ad12-transformed cell line HA12/7. Pulse-chase experiments combined with cell fractionation and immunofluorescence studies suggested that about 50% of the amount of the 58K polypeptide accumulates in the nucleus of infected KB cells at least at late times after infection, but only approximately 10% in Ad12-transformed cells. The 58K polypeptide is phosphorylated in both infected and transformed cells. Analysis of the products of acid hydrolysis indicates phosphorylation to equal amounts of serine and threonine. The implications of all these findings for possible roles of the E1B 58K tumor antigen in lytic infection and transformation are discussed.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000260 Adenoviruses, Human Species of the genus MASTADENOVIRUS, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. Serotypes (named with Arabic numbers) have been grouped into species designated Human adenovirus A-G. APC Viruses,APC Virus,Adenovirus, Human,Human Adenovirus,Human Adenoviruses
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000957 Antigens, Viral, Tumor Those proteins recognized by antibodies from serum of animals bearing tumors induced by viruses; these proteins are presumably coded for by the nucleic acids of the same viruses that caused the neoplastic transformation. Antigens, Neoplasm, Viral,Neoplasm Antigens, Viral,T Antigens,Tumor Antigens, Viral,Viral Tumor Antigens,Virus Transforming Antigens,Large T Antigen,Large T-Antigen,Small T Antigen,Small T-Antigen,T Antigen,T-Antigen,Viral T Antigens,Antigen, Large T,Antigen, Small T,Antigen, T,Antigens, T,Antigens, Viral Neoplasm,Antigens, Viral T,Antigens, Viral Tumor,Antigens, Virus Transforming,T Antigen, Large,T Antigen, Small,T Antigens, Viral,T-Antigen, Large,T-Antigen, Small,Transforming Antigens, Virus,Viral Neoplasm Antigens
D012694 Serine A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids. L-Serine,L Serine

Related Publications

K Schughart, and E Bause, and H Esche
May 1982, The Journal of general virology,
K Schughart, and E Bause, and H Esche
April 1980, Proceedings of the National Academy of Sciences of the United States of America,
K Schughart, and E Bause, and H Esche
October 1964, The Journal of experimental medicine,
K Schughart, and E Bause, and H Esche
April 1979, Journal of virology,
K Schughart, and E Bause, and H Esche
January 1983, Journal of virology,
K Schughart, and E Bause, and H Esche
September 1981, Journal of virology,
Copied contents to your clipboard!